Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06403202
Status:
RECRUITING
Last Update Posted:
2024-05-07
First Post:
2024-04-19
Brief Title:
Prognostic Performance of a Chemogram in Patients With Bladder Cancer
Sponsor:
Lille Catholic University
Organization:
Lille Catholic University
Study Overview
Official Title:
Prognostic Performance of a Chemogram in Patients With Intermediate-grade Superficial Bladder Cancer and Invasive Bladder Cancer Proof of Concept
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CHEMOGRAM
Brief Summary:
The aim of the study is to evaluate chemogram in patients with intermediate-grade superficial bladder cancer and patients with infiltrating bladder cancer who are likely to be treated according to the standard procedure This project is based on the premise that treatments - notably chemotherapy - are standard but that each cancer is unique It is therefore necessary to personalize the treatment for each patient while at the same time proposing an approach that is economically bearable for the healthcare system For both types of bladder tumor chemotherapy is used either as an alternative to immunotherapy or as an adjuvant to surgery Its use is therefore based on its effectiveness in reducing post-treatment recurrence
Detailed Description:
The project is based on the premise that treatments - particularly chemotherapy - are standard but that each cancer is unique It is therefore necessary to personalize treatment for each patient while proposing an approach that is economically viable for our healthcare system The chemogram is inspired by the principle of antibiograms since it tests for a given patient and in conjunction with oncologists different chemotherapeutic or targeted treatment options based on clinical and anatomopathological data These tests are carried out in vitro in academic research laboratories
With this study its proposed a proof of concept for the clinical use of chemograms in patients with superficial or infiltrating bladder cancer The use of chemograms will have no impact whatsoever on the patients treatment which will be administered according to standard practice Nevertheless this study may help determine whether chemograms can detect tumor sensitivity to certain anti-cancer treatments
In the years to come the aim of this research work is to be able to guide the therapeutic management of patients whose tumours are resistant to the treatment envisaged tumours with intrinsic resistance to treatment This will avoid unnecessary treatments for the patient often with very serious side effects
For these two types of bladder tumour the use of a chemogram to detect the tumours chemosensitivity would make treatment more effective and rapid
With this study its proposed a proof of concept for the clinical use of chemograms in patients with superficial or infiltrating bladder cancer The use of chemograms will have no impact whatsoever on the patients treatment which will be administered according to standard practice Nevertheless this study may help determine whether chemograms can detect tumor sensitivity to certain anti-cancer treatments
In the years to come the aim of this research work is to be able to guide the therapeutic management of patients whose tumours are resistant to the treatment envisaged tumours with intrinsic resistance to treatment This will avoid unnecessary treatments for the patient often with very serious side effects
For these two types of bladder tumour the use of a chemogram to detect the tumours chemosensitivity would make treatment more effective and rapid
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None